Argá Medtech today announced it closed a €54 million oversubscribed Series B funding round to support its pulsed field ablation technology. The Lausanne, Switzerland-based company develops the Coherent Sine-Burst Electroporation pulsed field ablation system for treating cardiac arrhythmias, including atrial fibrillation. Argá’s latest financing will allow the company to advance the development of its CSE […]
Catheters
Boston Scientific warns on fragment embolization in some PolarSheath devices
Boston Scientific has issued an urgent field safety notice for some of its PolarSheath steerable sheaths due to the risk of embolization. The company is removing specific batches of PolarSheath steerable sheaths due to a tooling error in manufacturing, which may have caused delimitation of the inner lumen of the sheath shaft in a subset […]
AngioDynamics sells PICC and Midline portfolios for $45M, discontinues sales of radiofrequency ablation devices
AngioDynamics recently announced the sale of its PICC and Midline product portfolios to Spectrum Vascular for up to $45 million in cash. The company PICC, Midline and tip location products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023. The transaction consists of $34.5 million paid at closing, an earnout related to […]
Ablation tech developer Adagio Medical to go public in SPAC deal
Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public. Upon the closing of the transaction, Adagio is set to become a subsidiary of Aja Holdco, still operating under its existing management team and under the name “Adagio Medical.” Arya expects to list the combined company’s […]
Pulse Biosciences reports positive 60-day evaluations for AFib-treating pulsed field ablation
Pulse Biosciences (Nasdaq:PLSE) today announced favorable findings from post-procedure evaluations of its CellFX pulsed field ablation system. The 60-day post-procedure evaluations looked at four initial patients treated in the company’s first-in-human feasibility study. This study, which kicked off in December 2023, looks at Pulse’s novel, proprietary CellFX nanosecond PFA technology for treating AFib. Dr. Vivek […]
Biotronik, IMDS launch new coronary microcatheter
Biotronik announced that it launched the Micro Rx catheter for enhancing guidewire support during percutaneous coronary interventions (PCI). Interventional Medical Device Solutions (IMDS) manufactures Micro Rx and Biotronik has exclusive distribution rights. Micro Rx marks the fourth IMDS product brought to the U.S. by Biotronik, joining the NHancer Rx, TrapIT and ReCross catheters. The Micro […]
J&J’s Cerenovus launches next-gen stroke revascularization catheter
Johnson & Johnson MedTech’s Cerenovus today announced the launch of its next-generation CereGlide 71 intermediate catheter with TruCourse. The catheter’s indication covers the revascularization of patients suffering from acute ischemic stroke. It joins the company’s planned CereGlide family of catheters set to enhance the Cerenovus Stroke Solutions portfolio. The company said it optimized the system […]
Innova Vascular has positive early commercial data for thrombectomy system
Innova Vascular today announced the successful early commercial use of its Laguna Thrombectomy System in California. The first physicians to use the system — Dr. Raj Khalsa and Dr. John Moriarty — reported positively after their initial cases. Khalsa touted the system’s easy preparation, strong trackability in challenging anatomies and effective clot extraction. “The design, […]
Biosense Webster has positive Varipulse pulsed field ablation data
Biosense Webster announced positive one-year results from multiple studies evaluating its Varipulse pulsed field ablation (PFA) system. Johnson & Johnson MedTech’s electrophysiology unit shared results from its inspIRE and admIRE studies. The inspIRE study looked at pulmonary vein isolation using a variable loop catheter with 3D mapping integration. The admIRE study used a variable loop […]
What’s next for Boston Scientific after Farapulse’s FDA approval?
Chief Medical Officer Dr. Ken Stein explains the plans at Boston Scientific after its landmark pulsed field ablation approval. On Jan. 31, Boston Scientific became the second company to receive FDA approval for a pulsed field ablation (PFA) system that treats AFib. The landmark approval came just over a month after Medtronic became the first […]
Study backs Biosense Webster low/zero fluoroscopy AFib ablation
Johnson & Johnson MedTech’s Biosense Webster announced positive findings from real-world data looking at its AFib ablation technology. The study evaluated the safety and effectiveness of low/zero fluoroscopy AFib ablation. Results supported the use of workflows to reduce radiation exposure during catheter ablation for treating paroxysmal AFib. Data also showed sustained safety, efficacy and long-term […]